Sector: Basic Materials | Industry: Diversified Chemicals |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 8145 BLAZER DRIVE WILMINGTON DE 19808 |
Tel: | 1-302-5945010 |
Website: | https://www.ashland.com |
IR: | See website |
Key People | ||
Guillermo Novo Chairman of the Board, Chief Executive Officer | Eric N. Boni Principal Accounting Officer, Vice President - Finance | John Kevin Willis Chief Financial Officer, Senior Vice President |
Eileen M. Drury Chief Human Resource Officer, Senior Vice President | Osama M. Musa Senior Vice President, Chief Technology Officer | Robin E. Lampkin Senior Vice President, General Counsel, Secretary |
Min Chong Senior Vice President, General Manager, Personal Care and Specialty Additives | Ashok S. Kalyana Senior Vice President, General Manager, Life Sciences and Intermediates | Karl Bostaph Senior Vice President - Operations | James Minicucci Senior Vice President - Strategy, Mergers and Acquisitions, and Portfolio Management |
Business Overview |
Ashland Inc. is a global specialty additives and materials company. The Company serves customers in a wide range of consumer and industrial markets, including architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceutical. The Company's segments include life sciences, personal care, specialty additives and intermediates. The life sciences segment is comprised of pharmaceuticals, nutrition, nutraceuticals, agricultural chemicals, diagnostic films and fine chemicals. The personal care segment is comprised of bio functionals, microbial protectants (preservatives), skin care, sun care, oral care, hair care and household solutions. The specialty additives segment is comprised of rheology and additives serving the architectural coatings, construction, energy, automotive and various industrial markets. Its Intermediates segment is comprised of the production of 1,4 butanediol (BDO) and related derivatives, including n-methyl pyrrolidone. |
Financial Overview |
For the three months ended 31 December 2023, Ashland Inc revenues decreased 10% to $473M. Net income before extraordinary items decreased 33% to $28M. Revenues reflect Specialty Additives segment decrease of 15% to $122M, Intermediates and Solvents segment decrease of 37% to $34M, Personal Care & Household segment decrease of 7% to $129M, Europe segment decrease of 15% to $154M, Asia Pacific segment decrease of 14% to $113M. |
Employees: | 3,800 as of Dec 31, 2023 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $5,779M as of Dec 31, 2023 |
Annual revenue (TTM): | $2,139M as of Dec 31, 2023 |
EBITDA (TTM): | $418.00M as of Dec 31, 2023 |
Net annual income (TTM): | $154.00M as of Dec 31, 2023 |
Free cash flow (TTM): | $232.00M as of Dec 31, 2023 |
Net Debt Last Fiscal Year: | $901.00M as of Dec 31, 2023 |
Shares outstanding: | 50,094,986 as of Dec 31, 2023 |
Index Membership: | S&P 400 Mid Cap |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |